Latest News
Kingfisher restarts dividend as profits soar on lockdown DIY boom
B&Q owner Kingfisher reinstated its dividend as annual profits soared on booming DIY demand from people stuck at home during the Covid-19 pandemic, but warned of a slowdown in sales growth in the second half.
MPs to decide on Greensill inquiry after Cameron lobbying
UK MPs will decide on Monday whether to investigate the collapse of Greensill Capital, including former prime minister David Cameron's attempts to lobby for the company, according to reports.
Futura Medical gets FDA OK for confirmatory study of erectile dysfunction gel
Futura Medical shares surged on Monday after the company said it had agreed with the US Food and Drug Administration on the protocol for a small confirmatory clinical study of its erectile dysfunction gel, MED3000.
Asia report: Markets mixed as China holds rates, lira in focus
Markets in Asia finished in a mixed state on Monday, as China’s central bank stood pat on interest rates, while investors kept an eye on developments in Turkey after a serious weakening in the lira over the weekend.
Knights Group to acquire Surrey-based commercial law firm
Legal and professional services outfit Knights Group has agreed to acquire Surrey-based independent commercial law firm Mundays from its six existing equity partners for a total consideration of £5. 3m.
Tremor International trades 'significantly ahead' of prior year in Q1
Video advertising technology firm Tremor International said on Monday that its first-quarter trading performance, historically the lowest quarter by revenue in the year, was "significantly ahead" of the same period in 2020.
Deliveroo targets value of up to £8.8bn in IPO
Deliveroo is seeking a market value of up to £8. 8bn at its initial public offering in what could be London's biggest IPO in a decade.
Shield taps Hans-Peter Rudolf as its new finance chief
Commercial-stage pharmaceuticals company Shield Therapeutics announced on Monday that Hans-Peter Rudolf was joining its senior executive team as chief financial officer, with immediate effect.
Citi upgrades Softcat, says premium valuation 'here to stay'
Citi upgraded its stance on shares of IT infrastructure and services provider Softcat on Monday to ‘neutral’ from ‘sell’ as it said the premium valuation is here to stay.
DX Group opens depot in Glasgow for express unit
Delivery solutions provider DX Group has continued the expansion of its network with the opening of a new depot in Glasgow.
Grainger appoints John Blanshard as director of operations
Residential landlord Grainger has appointed John Blanshard as its director of operations.
Botswana recovers 11 diamonds and 'abundant' kimerlitic indicators
Botswana Diamonds announce the recovery of 11 diamonds and “abundant” kimberlitic indicators from drill samples at the recently-discovered River kimberlite pipe on Monday, at Thorny River in South Africa’s Limpopo Province.
Eqtec expecting maiden profits in 2021
Gasification technology company Eqtec said on Monday that it expects to record maiden profits in 2021, with both new and existing projects set to bolster sales throughout the year.
Caledonia Mining profits grow after record year at Blanket
Caledonia Mining reported gross revenues of $100m (£72. 1m) in its full-year results on Monday, improving from $75. 8m year-on-year.
Europe open: Stocks lower on Turkish lira crisis, summer holiday fears
European shares opened the week in downbeat mood as the plunging Turkish lira and weak travel stocks hit markets.
Evgen appoints Helen Kuhlman as chief business officer
Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief business officer, taking up the role from 1 April.
Turkish lira drops after Erdogan sacks central bank chief
The Turkish lira fell heavily on Monday after the President Recep Tayyip Erdogan sacked his the head of the country's central bank.
Amryt's Myalepta gets reimbursement approval in France
Commercial-stage biopharmaceuticals company Amryt Pharma announced on Monday that the French Ministry of Social Affairs and Health has approved ‘Myalepta’, or metreleptin, for reimbursement in the country as an adjunct to diet as replacement therapy.
London open: Travel & leisure stocks pace the decline
London equity markets edged lower in early trade on Monday, with travel and leisure stocks pacing the decline amid a vaccine spat between the UK and EU and concerns about rising Covid cases in Europe.
Saudi Aramco pays $75m dividend despite profits slump
Oil giant Saudi Aramco paid out $75bn in dividends as it reported a sharp fall in annual profits on the back of a slump in demand due to the coronavirus travel bans and restrictions.